Iovance Biotherapeutics, Inc. IOVA Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s inventories?
- Iovance Biotherapeutics, Inc. (IOVA) reported inventories of $58.38M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s inventories changed year-over-year?
- Iovance Biotherapeutics, Inc.'s inventories decreased by 10.9% year-over-year, from $65.55M to $58.38M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s inventories?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s inventories has grown at a 173.3% compound annual growth rate (CAGR), from $29.29M to $218.77M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.